5. References

  1. DRUGDEX® System (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu/. Accessed March 23, 2022.
  2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2020. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed March 23, 2022.
  3. Albuterol sulfate inhalation solution 0.083% package insert. Nephron Pharmaceuticals Corp., August 2018.
  4. Albuterol sulfate inhalation solution 0.5% package insert. Nephron Pharmaceuticals Corporation, February 2007.
  5. Albuterol sulfate solution 0.63 mg/3 ml, 1.25 mg/3 ml package insert. Mylan Pharmaceuticals, Inc., October 2021.
  6. Levalbuterol inhalation solution (Xopenex®) package insert. Akorn, Inc., February 2022.
  7. Arformoterol inhalation solution (Brovana®) package insert. Sunovion Pharmaceuticals Inc., May 2021.
  8. Formoterol inhalation solution (Perforomist®) package insert. Mylan Specialty, May 2019.
  9. Revefenacin inhalation solution (Yupelri®) package insert. Mylan Specialty LP, November 2021.
  10. Glycopyrrolate inhalation solution (Lonhala Magnair®) package insert. Sunovian Pharmaceuticals Inc., August 2020.
  11. Ipratropium bromide inhalation solution 0.02% package insert. Actavis Pharmaceuticals, Inc., April 2017.
  12. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel 3: guidelines for the diagnosis and management of asthma. Full report 2007. NIH Publication No. 08-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.  Accessed March 23, 2022.
  13. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2021 update. Available at: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf. Accessed March 23, 2022.
  14. Ipratropium bromide and albuterol sulfate inhalation solution package insert. Aurobindo Pharma Limited, June 2020.
  15. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Accessed March 23, 2022.
  16. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. 2022 Report. Available at:  https://goldcopd.org/2022-gold-reports-2/. Accessed March 23, 2022.